Amit Dagar, a former Pfizer Inc (NYSE:PFE) employee, was found guilty of securities fraud for insider trading on Paxlovid trial news. He purchased stock options before the trial results were announced and tipped off a friend. Pfizer had previously cut its earnings and revenue guidance due to reduced demand for COVID-19 products. The FDA has approved Paxlovid under emergency use, and Pfizer is considering raising its price. PFE shares saw a slight decrease in premarket trading.